Maria Carmen Pérez-Martínez

Interferon/STAT1 and neuregulin signaling pathways are exploratory biomarkers of cetuximab (Erbitux®) efficacy in KRAS wild-type squamous carcinomas: a pathway-based analysis of whole human-genome microarray data from cetuximab-adapted tumor cell-line models.

Javier A Menendez, Joan Brunet, J. Brunet, 2011, International journal of oncology.

Diagnostic utility of mammaglobin and GCDFP-15 in the identification of primary neuroendocrine carcinomas of the breast

E. López-Bonet, B. Martín-Castillo, J. Menéndez, 2011, Breast Cancer Research and Treatment.

Mitotic kinase dynamics of the active form of AMPK (Phospho-AMPKαThr172) in human cancer cells

E. López-Bonet, J. Menéndez, A. Vázquez-Martín, 2009, Cell cycle.

Serine 2481-autophosphorylation of mammalian target of rapamycin (mTOR) couples with chromosome condensation and segregation during mitosis: confocal microscopy characterization and immunohistochemical validation of PP-mTOR(Ser2481) as a novel high-contrast mitosis marker in breast cancer core biops

E. López-Bonet, J. Menéndez, A. Vázquez-Martín, 2009, International journal of oncology.

Pathway-focused proteomic signatures in HER2-overexpressing breast cancer with a basal-like phenotype: new insights into de novo resistance to trastuzumab (Herceptin).

J. Brunet, E. López-Bonet, B. Martín-Castillo, 2010, International journal of oncology.